Ondansetron in pregnancy revisited: Assessment and pregnancy labelling
by the European Medicines Agency (EMA) & Pharmacovigilance Risk
Assessment Committee (PRAC).
- Per Damkier
18 Mar 2020Submitted to BJOG: An International Journal of Obstetrics and Gynaecology 19 Mar 2020Submission Checks Completed
19 Mar 2020Assigned to Editor
27 Mar 2020Reviewer(s) Assigned
13 Apr 2020Review(s) Completed, Editorial Evaluation Pending
28 Apr 2020Editorial Decision: Revise Major
